Peter Svennilson, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 300 shares at $4.98 ($1K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Open-market purchase of $1k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |
| RVMD | SELL | 2021-04-28 | $6.5M | — | Filing → |